HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth Pfarr Selected Research

muramyl- NAc- (pentapeptide)pyrophosphoryl- undecaprenol

12/2016NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae.
9/2009Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth Pfarr Research Topics

Disease

18Infections
01/2022 - 06/2009
12Filarial Elephantiasis (Lymphatic Filariasis)
11/2020 - 04/2006
8Onchocerciasis
08/2021 - 09/2008
5Filariasis
04/2019 - 06/2009
3Lymphedema (Milroy Disease)
01/2019 - 09/2006
2Intestinal Volvulus (Volvulus)
08/2021 - 10/2020
2Latent Infection
01/2018 - 11/2011
1Neoplasms (Cancer)
11/2019
1Mansonelliasis
01/2019
1Scrub Typhus (Typhus, Scrub)
01/2018
1Nematode Infections
11/2017
1Inflammation (Inflammations)
12/2016
1Epilepsy (Aura)
08/2016
1Leishmaniasis
02/2016
1Fibrosis (Cirrhosis)
11/2015
1Peritonitis
11/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2015
1Ascites
11/2015
1Neglected Diseases
12/2014
1Ocular Onchocerciasis (River Blindness)
08/2013
1Tuberculosis (Tuberculoses)
07/2012
1Coinfection
09/2008

Drug/Important Bio-Agent (IBA)

10Doxycycline (Periostat)FDA LinkGeneric
01/2019 - 04/2006
8Ivermectin (Mectizan)FDA Link
11/2021 - 04/2006
7Pharmaceutical PreparationsIBA
08/2021 - 09/2006
6corallopyronin AIBA
01/2022 - 07/2012
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2012
4Immunoglobulin G (IgG)IBA
01/2019 - 03/2014
3Proteins (Proteins, Gene)FDA Link
11/2017 - 11/2015
2Biomarkers (Surrogate Marker)IBA
08/2021 - 12/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2014
2Albendazole (Albenza)FDA Link
01/2019 - 04/2006
2muramyl- NAc- (pentapeptide)pyrophosphoryl- undecaprenolIBA
12/2016 - 09/2009
2AntigensIBA
03/2014 - 11/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 10/2007
1N-acetyltyramineIBA
08/2021
1cinnamoylglycineIBA
08/2021
1GlucuronidesIBA
08/2021
1Biological ProductsIBA
01/2021
1Antimalarials (Antimalarial Agents)IBA
11/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1CytokinesIBA
01/2019
1Tetracycline (Achromycin)FDA LinkGeneric
01/2018
1SulfonamidesIBA
01/2018
1QuinolonesIBA
01/2018
1Acetylmuramyl-Alanyl-IsoglutamineIBA
12/2016
1NucleotidesIBA
12/2016
1AntibodiesIBA
02/2016
1Immunoglobulin E (IgE)IBA
01/2016
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
11/2015
1Peptide Hydrolases (Proteases)FDA Link
08/2013
1Rifampin (Rifampicin)FDA LinkGeneric
07/2012
1leucylleucine (Leu-Leu)IBA
11/2011
1Diethylcarbamazine (Hetrazan)FDA Link
10/2009
1Vascular Endothelial Growth Factor CIBA
09/2006
1Complement System Proteins (Complement)IBA
09/2006

Therapy/Procedure

4Mass Drug Administration
01/2021 - 12/2014
3Aftercare (After-Treatment)
10/2020 - 09/2006
3Therapeutics
01/2018 - 09/2008